Global electrophoresis equipment & supplies market is expected to show a robust growth during the forecast period. This can be ascribed to the increasing rates of cancer, genetic disorders, and infectious diseases. For instance, according to World Cancer Research Fund, around 18,094,716 million cancer cases were diagnosed in 2020 around the globe which is also increasing the demand of electrophoresis equipment & supplies for clinical diagnosis. Additionally, rising funding for research activity in the fields of proteomics and genomics along with an increase in industry-academic research institute collaborations is expected to spur the growth of global electrophoresis equipment & supplies market. Research initiatives involving proteins and genes are becoming more prevalent, and there is an increasing need for novel medications and treatments. Besides, a growing emphasis on next-generation sequencing (NGS) and associated research activities is further contributing to the growth of global electrophoresis equipment & supplies market. The National Comprehensive Cancer Network (NCCN) recommends using NGS for a variety of tumor types, including non-small cell lung, breast, colon, ovarian, and pancreatic cancers, which account for the majority of occurrences in the United States due to which rise in the demand for electrophoresis equipment & supplies market is growing rapidly.
The biopharmaceutical industry has experienced significant growth in recent years, with an increasing focus on developing biologics, such as antibodies, vaccines, and recombinant proteins. Electrophoresis is widely used in the characterization and quality control of these biopharmaceutical products, ensuring their purity, identity, and consistency. As the biopharmaceutical industry expands, the demand for electrophoresis equipment also rises.
Electrophoresis techniques are used in clinical diagnostics for various applications, such as hemoglobinopathy screening, protein profiling, and identification of genetic disorders. With advancements in precision medicine and personalized healthcare, the demand for electrophoresis equipment in clinical diagnostics is expected to rise. This in turn is expected to create lucrative opportunities for the growth of global electrophoresis equipment & supplies market during the forecast period.
Increasing Financial Support for Genomes and Proteomics-Related Research and Development
One of the main drivers for the growth of the electrophoresis equipment and supplies market at the worldwide level is the rise in biochemistry research activities and medical research projects. Private investments in R&D are growing rapidly, with United States and China spending high share in R&D funding on experimental development in comparison to other countries. According to a report published by Federation of American Scientists, the investment in R&D have tripled since 2000, reaching to $2.4 trillion from $675 billion in 2020.
One of the things driving the expansion of the electrophoresis equipment and supply market is the growing complexity of treating diseases like cancer, genetically transmitted diseases, and other health problems. The use of capillary electrophoresis equipment and supplies in disciplines like protein analysis and microbial detection is increasing their popularity as the results are obtained quickly with great accuracy.
The need for electrophoresis equipment and supplies is increasing because to the recent rise in biological research activities in several fields, including research and academic institutes, hospitals, and others, for performing DNA analysis, sequencing, and other operations. Additionally, the necessity for the deployment of effective and automatic equipment, such as electrophoresis supplies and equipment, is growing quickly due to increased competition among pharmaceutical and biotechnology companies as electrophoresis is widely used in determining drugs and/or excipients in various pharmaceutical preparations. Since these industrial verticals use electrophoresis equipment & supplies for antibody research, drug discovery, and other purposes, the applications for electrophoresis equipment and supplies are anticipated to grow significantly over the forecast period.
Introduction of Automated Electrophoresis Systems with Cutting-Edge Capabilities
The demand for automated electrophoresis systems may increase as laboratories seek to improve efficiency, reduce human error, and increase throughput. Automated systems that offer higher sample throughput and integrated data analysis capabilities may become more popular in the future. Now that electrophoresis systems have recently advanced, there is opportunity for the market to seek new applications. Numerous novel technologies have been developed in past few years, including SDS PAGE, 2D gel electrophoresis, polyacrylamide gel electrophoresis, and PerkinElmer's microfluidic electrophoresis platforms. Many of these technologies have produced outcomes that are incredibly encouraging. Additionally, funding for the advancement of electrophoresis technology has increased significantly.
The demand for medical breakthroughs has been rising on a global scale. The pharmaceutical and biotechnology industry are being forced by the rising incidence of new diseases to create new medications or vaccinations that can combat the emerging viral infections which has resulted an increase in pharmaceutical innovation due to which the demand for electrophoresis is increasing rapidly for drug discoveries. For instance, the PubMed data released in July 2021 indicates that the use of electrophoresis in pharmaceutical development is increasing. The electrophoresis method is used by researchers in pharmaceutical analysis. Scientists are more focused in the development of microchip capillary electrophoresis for rapid separation to monitor mRNA purity and integrity which is important in the faster vaccine development due to which the demand for electrophoresis equipment are increasing.
Increasing Analysis of Energy Drinks Using Capillary Electrophoresis
The low specimen and reagent volume consumption, short analysis time, low operating cost, high-definition strength, increased removal efficacy, ease of experimentation, and quick process development is making capillary electrophoresis technologies useful for evaluating foods and beverages. The capabilities of capillary electrophoresis for the identification of nitrogen-containing chemical compounds and ascorbic acid in beverages, as well as the impact of electrophoresis variables on the technique's quantitative properties, are the subjects of a recent study published in the International Conference for Agricultural and Sustainability. This in turn is expected to spur the growth of global electrophoresis equipment & supplies market in the next few years.
The low cost, environmental friendliness, asymmetrical spikes in organic acid or basic assessment, and environmental compatibility of the research are advantages of capillary electrophoresis over high-performance liquid chromatography. With just a few fundamental factors (test dispersion in the running buffer, supply of buffer compositional uniformity, and thermostating of the separating layer), capillary electrophoresis provides adequate precision in the detection of labile substances in a complex matrix.
Recent Developments
MiniPCR Bio, a producer of scientific equipment for researchers, announced the release of the Bandit STEM Electrophoresis Kit in September 2022.
In August 2022, the availability of the new CALX8 Reagent for life science laboratory researchers was announced by Amerigo Scientific, a distributor that serves the needs of the biomedical and life science communities. This reagent is frequently used in molecular biology research techniques such as cell lysis, protein purification, electrophoresis, and immunoassays.
In May 2022, QIAGEN announced the release of QIAxcel Connect, a capillary electrophoresis (CE) instrument for high-speed, high-resolution, and high-sensitivity nucleic acid analysis.
In 2021, introduction of cutting-edge DNA testing capabilities by laboratory service provider Genelab was launched after acquiring Compact Spectrum CE system. An automated four-capillary electrophoresis device called the Compact Spectrum is used for a variety of DNA fragment assays, including paternity testing and Sanger sequencing. The facility, which is an expansion of the company's services, is anticipated to offer solutions for forensic tests, DNA sequencing, and paternity tests. Modern molecular biology services will be easily accessible due to the Promega Spectrum Compact, which is the first of its type in West Africa.
Sebia SA, a French company that is a global leader in the medical industry, opened its first office in the Gulf Cooperation Council (GCC) in Dubai in 2020. To assist distributors in the Middle East, Turkey, and Pakistan, Sebia claimed to have opened a distribution and marketing office in Dubai. The Paris-based company will provide electrophoresis equipment from its Dubai headquarters for use in in vitro diagnostic testing for conditions including diabetes, which affects nearly one in five UAE residents today, and myeloma, a type of cancer.
In 2019, Syngene announced the release of a brand-new line of durable horizontal and vertical gel electrophoresis equipment. The new units give scientists a simple, adaptable platform to run DNA and protein gels of consistently high quality for visualization in Syngene's imaging systems, saving them time and effort.
In November 2019, PerkinElmer Inc. provided two microfluidic electrophoresis systems, including the LabChip GX Touch nucleic acid analyzer for DNA and RNA and the LabChip GXII Touch Protein characterisation system for proteins and glycans.
Advanced Analytical Technologies, Inc. (AATI), one of the top producers of computerized and automated capillary electrophoresis devices, was acquired by Agilent Technologies, Inc. in May 2018. Agilent Technologies is advancing towards solidifying its position in the market with this acquisition.
Market Segmentation
Global electrophoresis equipment & supplies market is segmented by type, product, end user,
Market Players
Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Helena Laboratories Corporation, Hoefer Inc., Lonza Group Ltd., Merck KGaA, PerkinElmer Inc., SCIEX, SERVA Electrophoresis GmbH, Thermo Fischer Scientific Inc. are among the major market players operating in the Global Electrophoresis equipment & supplies Market.
Attribute | Details |
Base Year | 2022 |
Historical Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · By Type · By Product · By End User |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States, Canada, Mexico, France, United Kingdom, Italy, Germany, Spain, China, India, Japan, Australia, South Korea, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE, Kuwait, Turkey, Egypt |
Key companies profiled | Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Helena Laboratories Corporation, Hoefer Inc., Lonza Group Ltd., Merck KGaA, PerkinElmer Inc., SCIEX, SERVA Electrophoresis GmbH, Thermo Fischer Scientific Inc. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |